Role of cytomegalovirus on the maturation and function of monocyte derived dendritic cells of liver transplant patients

Table 1 Underlying diseases in liver transplanted patients

Underlying diseases	Patients (n = 10)
PSC	2
Hypercholesterolemia	1
Cryptogenic cirrhosis	2
Hepatitis C virus infection	1
Hepatitis B virus infection	1
Wilson disease	1
NASH	1
Autoimmune hepatitis	1

PSC: Primary sclerosing cholangitis; NASH: Non-alcoholic steato-hepatitis.

Table 2 Average means fluorescence intensity for surface markers of monocyte derived dendritic cells in cytomegalovirus reactivated, non-reactivated liver transplanted recipients, and healthy individuals

Surface marker	CMV reactivated patients	CMV non-reactivated patients	Healthy controls of MoDCs
	MFI ± SE	MFI ± SE	MFI ± SE
CD83	30.15 ± 1.06	32.3 ± 2.3	29.2 ± 2.5
CD86	100.5 ± 3.1	103 ± 4.5	83 ± 6.7
CD1a	47 ± 1	80 ± 3	53 ± 13
HLA-DR	49.3 ± 5.4	73.6 ± 6.5	55.8 ± 4.9

The data are the means ± SE. MFI: Mean fluorescence intensity; HLA-DR: Human leukocyte antigen DR; CMV: Cytomegalovirus; MoDC: Monocyte derived dendritic cell.